Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Devon Energy
DVN
|
+$196M |
| 2 |
Verizon
VZ
|
+$166M |
| 3 |
Edison International
EIX
|
+$152M |
| 4 |
PPL
PPL Corp
PPL
|
+$122M |
| 5 |
Estee Lauder
EL
|
+$115M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ameren
AEE
|
+$140M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$136M |
| 3 |
ANDV
Andeavor
ANDV
|
+$111M |
| 4 |
LyondellBasell Industries
LYB
|
+$105M |
| 5 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$101M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.77% |
| 2 | Energy | 13.48% |
| 3 | Utilities | 8.99% |
| 4 | Financials | 8.47% |
| 5 | Consumer Discretionary | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
C.H. Robinson
CHRW
$16.5B
| $14.3M | 0.04% |
273,577
-4,112
| -1% | -$224K |
|
602
Pitney Bowes
PBI
$2.26B
| $14.3M | 0.04% |
550,422
-231,692
| -30% | -$5.71M |
|
603
ANI Pharmaceuticals
ANIP
$1.73B
| $14.3M | 0.04% |
+456,223
| New | +$12.1M |
|
|
KATE
604
DELISTED
Kate Spade & Company
KATE
| $14.3M | 0.04% |
384,518
+71,303
| +23% | +$2.36M |
|
|
FNBC
605
DELISTED
First NBC Bank Holding Company
FNBC
| $14.2M | 0.04% |
406,949
-77,848
| -16% | -$2.57M |
|
|
ARGO
606
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $14.1M | 0.04% |
428,457
+380,975
| +802% | +$12.4M |
|
|
PX
607
CALL
DELISTED
Praxair Inc
PX
| $14.1M | 0.04% |
+107,700
| New | +$14M |
|
608
Dillards
DDS
$9.71B
| $14.1M | 0.04% |
152,521
+109,808
| +257% | +$9.94M |
|
609
O'Reilly Automotive
ORLY
$72.1B
| $14.1M | 0.04% |
1,423,035
+180,360
| +15% | +$1.72M |
|
610
W&T Offshore
WTI
$592M
| $14.1M | 0.04% |
812,652
-214,266
| -21% | -$3.23M |
|
611
Liberty Media Series A
FWONA
$24.2B
| $14M | 0.04% |
604,754
-41,789
| -6% | -$999K |
|
612
PUT
Nokia
NOK
$57B
| $14M | 0.04% |
+1,913,400
| New | +$14.4M |
|
|
FNFG
613
DELISTED
FIRST NIAGARA FINANCIAL GROUP INC
FNFG
| $14M | 0.04% |
1,484,954
+1,177,561
| +383% | +$10.9M |
|
|
SGNT
614
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $14M | 0.04% |
597,431
+247,295
| +71% | +$5.41M |
|
|
EZCH
615
PUT
DELISTED
EZCHIP SEMICONDUCTOR LIMITED ORD SHS (IL)
EZCH
| $14M | 0.04% |
+550,500
| New | +$14.1M |
|
|
DANG
616
DELISTED
E-COMMERCE CHINA DANGDANG INC SPNSRD ADS REP COM CL A (CYM)
DANG
| $13.9M | 0.04% |
970,653
+406,266
| +72% | +$4.89M |
|
|
SRCL
617
DELISTED
Stericycle Inc
SRCL
| $13.9M | 0.04% |
122,648
-23,994
| -16% | -$2.77M |
|
|
CTB
618
DELISTED
Cooper Tire & Rubber Co.
CTB
| $13.9M | 0.04% |
+573,434
| New | +$13.7M |
|
|
ITMN
619
DELISTED
INTERMUNE INC
ITMN
| $13.9M | 0.04% |
416,131
-112,319
| -21% | -$2.5M |
|
620
Fluor
FLR
$7.01B
| $13.9M | 0.04% |
179,097
+163,289
| +1,033% | +$12.7M |
|
621
TherapeuticsMD
TXMD
$23.8M
| $13.9M | 0.04% |
44,100
+7,660
| +21% | +$2.44M |
|
|
BHI
622
CALL
DELISTED
Baker Hughes
BHI
| $13.9M | 0.04% |
+213,900
| New | +$12.7M |
|
|
EXXI
623
DELISTED
ENERGY XXI LTD COM SHS
EXXI
| $13.8M | 0.04% |
585,554
+506,311
| +639% | +$11.9M |
|
624
CALL
Amazon
AMZN
$2.79T
| $13.8M | 0.04% |
820,000
+432,000
| +111% | +$8.02M |
|
625
CALL
H&R Block
HRB
$6.62B
| $13.8M | 0.04% |
+456,800
| New | +$13.7M |
|
Similar funds
Israel Englander's Q1 2014 Portfolio in Review
As of Q1 2014, Israel Englander held 4,356 positions worth $34.5B, up 8.9% from $31.7B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Israel Englander deployed $1.49B of net new capital in Q1 2014, opening 945 new positions and adding to 1,266 existing holdings. Its largest new stake was Bausch Health: 575,504 shares worth $75.9M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Energy and Utilities.
On the sell side, the largest reduction was Ameren, an estimated $140M trimmed.
- Israel Englander's largest Q1 2014 buy was Bausch Health: 575,504 shares worth $75.9M.
- Israel Englander added most to Devon Energy in Q1 2014, an estimated $196M increase.
- Israel Englander's biggest Q1 2014 reduction was Ameren, cutting an estimated $140M.
- Israel Englander fully exited PepsiCo in Q1 2014, selling an estimated $89.1M.
- Israel Englander's ten largest holdings make up 7.9% of its $34.5B portfolio in Q1 2014.
- Israel Englander opened 945 new positions and closed 958 in Q1 2014.
- Israel Englander's portfolio value rose 8.9% quarter-over-quarter to $34.5B.
Based on Millennium Management's 13F filing for Q1 2014, filed 15 May 2014.